Lab of ImmunoEngineering and ImmunoTheranostics VCU School of Pharmacy

Home

Header navigation

Research


“Very recent research efforts in the lab concern combination cancer immunotherapy based on nanovaccines and nanomedicines, mRNA therapeutics, STING-activating immunomodulators, and gene-editing nanomedicines. “

Our Research


The Work We Do


Our research interests lie at the interface of immune-oncology, nucleic acid therapeutics, nanomedicine, pharmacoengineering and pharmacoimaging. My current focus is to develop “off-the-shelf” nucleic acid nanomedicines to modulate the immune system to treat cancer, and to interrogate the immuno-nano interfaces. My long-term goal is to implement immunotherapy to a broad population of patients. These interests often involve the following areas:

  • ImmunoEngineering
  • ImmunoTheranostics
  • Nanovaccine
  • Nanomedicine
  • Nucleic acid therapeutics and probes (immunomodulatory DNA/RNA, mRNA, siRNA/shRNA, plasmid, Aptamer, etc)
  • Cancer and immune disorders


Very recent research efforts in the lab concern combination cancer immunotherapy based on nanovaccines and nanomedicines, mRNA therapeutics, STING-activating immunomodulators, and gene-editing nanomedicines.

View Publications
View graphic versionView graphic version